Scotoma Reduction in AMD Patients Treated With Ranibizumab

• Status: Completed
• Trial end date: 2007-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Retina Research Foundation
• Treatments: Ranibizumab

Criteria

Inclusion Criteria:

• BCVA < 20/320

• Disciform macular degeneration wiht exudation

Exclusion Criteria:

• Non-amd CNV